| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 26399 | 2017 |
| Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Antithrombotic Trialists' Collaboration Bmj 324 (7329), 71-86, 2002 | 13742* | 2002 |
| 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The … G Hindricks, T Potpara, N Dagres, E Arbelo, JJ Bax, ... European heart journal 42 (5), 373-498, 2021 | 10449 | 2021 |
| 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of … F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ... European heart journal 41 (1), 111-188, 2020 | 9518 | 2020 |
| Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials C Baigent, L Blackwell, J Emberson, LE Holland, C Reith, N Bhala, R Peto, ... The Lancet 376 (9753), 1670-1681, 2010 | 8602* | 2010 |
| 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ... Polish Heart Journal (Kardiologia Polska) 73 (12), 1207-1294, 2015 | 8235 | 2015 |
| Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins ES Unit Lancet 366 (9493), 1267-1278, 2005 | 8151 | 2005 |
| 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the … J Knuuti, W Wijns, A Saraste, D Capodanno, E Barbato, ... European heart journal 41 (3), 407-477, 2020 | 7804 | 2020 |
| European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other … European Journal of Preventive Cardiology 19 (4), 585-667, 2012 | 7262 | 2012 |
| Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Prospective Studies Collaboration The Lancet 373 (9669), 1083-1096, 2009 | 6330 | 2009 |
| 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute … JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ... European heart journal 42 (14), 1289-1367, 2021 | 5828 | 2021 |
| 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the … SV Konstantinides, G Meyer, C Becattini, H Bueno, GJ Geersing, ... European heart journal 41 (4), 543-603, 2020 | 5145 | 2020 |
| 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of … A Vahanian, F Beyersdorf, F Praz, M Milojevic, S Baldus, J Bauersachs, ... European heart journal 43 (7), 561-632, 2022 | 4961 | 2022 |
| 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 4909 | 2020 |
| Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. C Baigent, L Blackwell, R Collins, J Emberson, J Godwin, R Peto, J Buring, ... Lancet 373 (9678), 1849-1860, 2009 | 3785 | 2009 |
| Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials BPLT Trialists’Collaboration, F Turnbull Lancet 362 (9395), 1527-1535, 2003 | 3144 | 2003 |
| The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo … C Baigent, MJ Landray, C Reith, J Emberson, DC Wheeler, C Tomson, ... The Lancet 377 (9784), 2181-2192, 2011 | 3034 | 2011 |
| Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient … J Emberson, KR Lees, P Lyden, L Blackwell, G Albers, E Bluhmki, T Brott, ... The Lancet 384 (9958), 1929-1935, 2014 | 2819 | 2014 |
| The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, EH Barnes, ... Lancet (London, England) 380 (9841), 581-590, 2012 | 2389 | 2012 |
| Cholesterol Treatment Trialists'(CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 … C Baigent Lancet 366, 1267-1278, 2005 | 2138 | 2005 |
